Welcome to our dedicated page for USANA Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on USANA Health Sciences stock.
USANA Health Sciences Inc (NYSE: USNA) is a U.S.-based company that specializes in developing, manufacturing, and distributing science-backed nutritional and personal-care products. Founded in 1992 by the internationally recognized microbiologist and immunologist, Dr. Myron Wentz, USANA is committed to enhancing the well-being of its customers through high-quality health products. The company operates primarily through a network marketing model, providing rewarding financial opportunities for its independent associates, shareholders, and employees.
USANA's product lines are comprehensive and diverse, catering to various health and nutritional needs. The Essentials line includes core vitamin and mineral supplements. Optimizers offer targeted supplements for specific health requirements. The Foods line features low-glycemic meal replacement shakes and snack bars, promoting balanced nutrition. Sense Beautiful Science offers personal-care products designed for skin and hair health. These products are developed and manufactured in top-notch facilities, ensuring the highest standards of quality and efficacy.
The company's influence extends globally, with operations in Asia-Pacific, the Americas, and Europe. USANA's commitment to innovation is reflected in their proprietary technologies, such as the award-winning InCelligence Technology™ used in their products. Recent achievements include multiple awards at the Korea Medical Healthcare Awards, where USANA's HealthPak and Nutrimeal Active were recognized for their excellence in the multivitamin and weight management categories, respectively.
USANA emphasizes continuous learning and personal growth, as highlighted by their leadership's advocacy for a growth mindset and self-care initiatives. Kevin Guest, the executive chairman of USANA, frequently shares insights that underline the importance of personal development and community contribution. For instance, during Leap Day 2024, Guest proposed seven strategies for making the most of the extra day, ranging from meditation to volunteering.
Moreover, USANA’s financial health and operational integrity have been robust, thanks to their clear communication and strong relationships with customers and distributors across 25 countries. Their dedication to quality and excellence has earned them a solid reputation, making USANA a trusted name in health and wellness. To learn more about their latest products and initiatives, visit their official website at USANA.com.
USANA, a leader in cellular nutrition, received three major awards during the 2021 Direct Selling Association (DSA) Engage Conference. The company won the Product Innovation award for its Mood and Relaxation Products and the Vision for Tomorrow award for its charity, USANA Kids Eat. Additionally, Sarah Searle, USANA's Director of Communications, was named PR Professional of the Year. USANA has over 750 awards to its name since 1992, underscoring its commitment to innovation and community support.
On Nov. 1, 2021, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), emphasized five strategies for employees to stay relevant during the pandemic, coinciding with Job Action Day. He encourages taking ownership of one’s career, forming informed opinions, mastering technology, utilizing one's voice, and pursuing professional development. These practices can enhance visibility and influence within organizations. Guest's insights are drawn from his bestselling book, All the Right Reasons, aimed at helping individuals achieve career success while contributing to feeding hungry children.
USANA Health Sciences (NYSE: USNA) reported fiscal Q3 2021 results with net sales of $274.4 million, down 8% from the previous year. Diluted EPS was $1.36, a 6% decrease. Active customers dropped to 576,000, down 11%. The Asia Pacific region, contributing 81% of sales, saw net sales of $220.9 million (-9%). The company maintains its fiscal 2021 outlook for consolidated net sales of $1.18 - $1.20 billion and EPS of $5.80 - $6.00. USANA ended the quarter with $249 million in cash.
USANA announced that its Coenzyme Q10 supplement, CoQuinone 30, has received a purity and label accuracy seal from ConsumerLab.com. This marks the third time CoQuinone 30 has achieved this recognition. The product contains 100% of the claimed CoQ10 amount and combines CoQ10 with alpha-lipoic acid, enhancing its effectiveness for cellular energy and supporting cardiovascular health. USANA also has other certified products, including BiOmega and Procosa.
USANA Health Sciences (NYSE: USNA) appointed Xia Ding to its board of directors, effective October 11, 2021. Ms. Ding is currently Nike's Vice President of e-commerce for Asia Pacific and Latin America and brings extensive experience from leading companies like JD.com and Hanesbrands. With her expertise in digital business, USANA aims to enhance its strategic direction. Following this addition, the board comprises eight members, six of whom are independent. CEO Kevin Guest expressed optimism regarding Ms. Ding's contributions to the company’s growth.
USANA Health Sciences (NYSE: USNA) will announce its third quarter 2021 results after the close of the market on October 26, 2021. Following the earnings release, a Management Commentary document will be available on the company’s website. A conference call to discuss the results with analysts will take place on October 27, 2021, at 11:00 AM ET. The call will be accessible via the Investor Relations section of their site.
For further information, visit ir.usana.com.
USANA congratulates board member Peggie Pelosi for being named one of the most influential leaders by the National Association of Corporate Directors (NACD). This recognition is part of the NACD Directorship 100™, which honors corporate governance experts and directors who significantly impact boardroom practices. Pelosi's contributions to sustainability and corporate social responsibility have been highlighted, and she will be recognized at a virtual gala on November 9, 2021. Her leadership is praised by Kevin Guest, USANA's CEO.
USANA Health Sciences has collaborated with Dr. Mehmet Oz and Dr. Anlong Xu to publish Yin Yang You, a book that integrates Traditional Chinese Medicine (TCM) with Western health practices. Launched at the 2021 Concordia Annual Summit, this innovative guide aims to demystify TCM for Western audiences, offering practical insights and recipes. The collaboration emphasizes enhancing understanding of holistic health and aims to bridge the gap between Eastern and Western medicine, promoting global awareness and effectiveness in health practices.
USANA Health Sciences (NYSE: USNA) has announced preliminary results for Q3 2021, reporting net sales between
USANA, a provider of cellular nutrition products, has received its third seal of approval from ConsumerLab.com for its Procosa joint-support supplement. This recognition confirms that Procosa contains 100% of the claimed amounts of glucosamine and turmeric, essential for joint health. The supplement also meets strict standards for heavy metals and disintegration levels. Dan Macuga, USANA's CMO, highlighted the company's dedication to quality in its products. USANA's reputation for high-quality supplements is further strengthened by multiple certifications from ConsumerLab.com, reinforcing its commitment to consumer trust.
FAQ
What is the current stock price of USANA Health Sciences (USNA)?
What is the market cap of USANA Health Sciences (USNA)?
What is USANA Health Sciences?
When was USANA founded?
What are USANA's main product lines?
How does USANA distribute its products?
What recent awards has USANA won?
What is USANA's InCelligence Technology?
Who is Kevin Guest?
Where does USANA operate?
What is USANA's mission?
How can I learn more about USANA's products?
